{"id":"W4283701700","doi":"10.1016/j.ejca.2022.05.007","title":"Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study","year":2022,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Merck","keywords":"Pembrolizumab; Salivary gland; Medicine; Carcinoma; Oncology; Internal medicine; Pathology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002913849,0.0008061224,0.001485031,0.0001952505,0.0002710145,0.0007234439,0.0006485519,0.0008499536,0.003098917],"category_scores_gemma":[0.0009661802,0.0003524437,0.0008898015,0.0002201158,0.0002529614,0.0007422012,0.000390797,0.00155119,0.00077661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000737483,"about_ca_system_score_gemma":0.001090865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002957191,"about_ca_topic_score_gemma":0.001030384,"domain_scores_codex":[0.9993124,0.0003936523,0.00005243629,0.0001011277,0.00007591803,0.00006456784],"domain_scores_gemma":[0.999409,0.00009049664,0.0001864129,0.00005336583,0.00007209808,0.0001886272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5073573,0.04139423,0.05046065,0.003810377,0.004862396,0.0007936811,0.0004221637,0.003132362,0.1043698,0.0004908884,0.01106543,0.2718408],"study_design_scores_gemma":[0.3989156,0.4624753,0.1012616,0.000270647,0.002218154,0.001522355,0.0001220407,0.002892923,0.008667666,0.0002779693,0.02130338,0.00007227947],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875119,0.006201801,0.0004644429,0.0004804525,0.0001074923,0.001620774,0.00115489,0.00008314286,0.002375182],"genre_scores_gemma":[0.9888138,0.002595588,0.001322386,0.00102323,0.0001663092,0.001653229,0.002809612,0.00001653933,0.001599207],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003098917,"threshold_uncertainty_score":0.01541007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02752118178310694,"score_gpt":0.3232095080446759,"score_spread":0.295688326261569,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}